Michael E. Kallen

809 total citations
51 papers, 499 citations indexed

About

Michael E. Kallen is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Michael E. Kallen has authored 51 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Michael E. Kallen's work include Sarcoma Diagnosis and Treatment (9 papers), Lymphoma Diagnosis and Treatment (9 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Michael E. Kallen is often cited by papers focused on Sarcoma Diagnosis and Treatment (9 papers), Lymphoma Diagnosis and Treatment (9 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Michael E. Kallen collaborates with scholars based in United States, France and Czechia. Michael E. Kallen's co-authors include Jason L. Hornick, Katherine R. Calvo, Alina Dulau‐Florea, Weixin Wang, Sheeja T. Pullarkat, Carlos A Tirado, Bita V. Naini, Anatoly Grishin, Jeffrey S. Upperman and Noemı́ Tejera and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Michael E. Kallen

42 papers receiving 493 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael E. Kallen United States 10 218 152 100 82 65 51 499
Katarzyna Drabko Poland 14 199 0.9× 86 0.6× 35 0.3× 83 1.0× 58 0.9× 78 498
E. Poncelet France 17 188 0.9× 86 0.6× 89 0.9× 126 1.5× 45 0.7× 54 1.4k
Roberto Cassandro Italy 19 669 3.1× 125 0.8× 109 1.1× 120 1.5× 59 0.9× 41 1.0k
Yukari Ichikawa Japan 12 279 1.3× 62 0.4× 118 1.2× 48 0.6× 62 1.0× 32 492
İrem Hicran Özbudak Türkiye 11 257 1.2× 82 0.5× 53 0.5× 125 1.5× 70 1.1× 51 573
ST Yuen China 8 180 0.8× 127 0.8× 49 0.5× 115 1.4× 103 1.6× 13 526
David B. Chapel United States 15 422 1.9× 123 0.8× 60 0.6× 83 1.0× 63 1.0× 54 739
Pridvi Kandagatla United States 9 105 0.5× 178 1.2× 55 0.6× 109 1.3× 16 0.2× 29 423
H. Aubert France 13 97 0.4× 80 0.5× 42 0.4× 112 1.4× 50 0.8× 68 714
Mami Morita Japan 13 129 0.6× 127 0.8× 50 0.5× 94 1.1× 31 0.5× 38 550

Countries citing papers authored by Michael E. Kallen

Since Specialization
Citations

This map shows the geographic impact of Michael E. Kallen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Kallen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Kallen more than expected).

Fields of papers citing papers by Michael E. Kallen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael E. Kallen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Kallen. The network helps show where Michael E. Kallen may publish in the future.

Co-authorship network of co-authors of Michael E. Kallen

This figure shows the co-authorship network connecting the top 25 collaborators of Michael E. Kallen. A scholar is included among the top collaborators of Michael E. Kallen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael E. Kallen. Michael E. Kallen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kallen, Michael E., Cinthia B. Drachenberg, & Teklu Legesse. (2024). Lesson of the Month: perinephric myxoid pseudotumor of fat co‐occurring with polycystic kidney disease. Histopathology. 85(3). 521–522. 2 indexed citations
2.
Thompson, Jeffrey C., Caitlin M. Tilsed, Christiana Davis, et al.. (2024). Predictive Signatures for Responses to Checkpoint Blockade in Small-Cell Lung Cancer in Second-Line Therapy Do Not Predict Responses in First-Line Patients. Cancers. 16(16). 2795–2795. 1 indexed citations
3.
4.
Kallen, Michael E., et al.. (2024). Malignant Melanotic Nerve Sheath Tumor – A Pitfall in the Diagnosis of Schwannoma. International Journal of Surgical Pathology. 33(3). 670–672.
5.
Luetkens, Tim, Rima Koka, Michael E. Kallen, et al.. (2024). Treatment of secondary CNS lymphoma using CD19-targeted chimeric antigen receptor (CAR) T cells. Cancer Immunology Immunotherapy. 73(3). 45–45. 5 indexed citations
6.
Kallen, Michael E., et al.. (2024). Updates in the role of the tumor microenvironment cellular crosstalk and genetic signatures in diffuse large B-cell lymphoma: a narrative review. Chinese Clinical Oncology. 13(3). 38–38. 2 indexed citations
7.
Kallen, Michael E., et al.. (2023). Macrophage activation syndrome after granulocyte colony‐stimulating factor in a patient with systemic lupus erythematosus. British Journal of Haematology. 204(3). 747–748.
8.
Koka, Rima, Michael E. Kallen, Aaron P. Rapoport, et al.. (2023). A Subset of Classical Hodgkin Lymphoma Cases Demonstrate CD19 Expression on Hodgkin Reed-Sternberg Cells By Immunohistochemistry. Blood. 142(Supplement 1). 6125–6125. 1 indexed citations
9.
Kobayashi, Hirofumi, et al.. (2023). Real-time, multiplexed rendering of lymphoma diagnostic panels from unstained tissue sections using virtual staining.. JCO Global Oncology. 9(Supplement_1). 115–115. 1 indexed citations
10.
Chen, Wengen, Michael E. Kallen, Rima Koka, et al.. (2023). Chimeric antigen receptor (CAR) T cells for the treatment of a kidney transplant patient with post-transplant lymphoproliferative disorder (PTLD). Human Vaccines & Immunotherapeutics. 19(2). 2216116–2216116. 4 indexed citations
11.
Blackwell, Courtney K., Jin‐Shei Lai, Michael E. Kallen, et al.. (2022). Measuring PROMIS® Social Relationships in Early Childhood. Journal of Pediatric Psychology. 47(5). 573–584. 4 indexed citations
12.
Kallen, Michael E., Christopher N. Otis, & Paul N. Staats. (2022). Reporting Critical/Urgent/Significant Results in Anatomic Pathology: The Devil Is in the Details. 27(4). 166–170.
13.
Kallen, Michael E., Rima Koka, Zeba N. Singh, et al.. (2022). Therapy-related B-lymphoblastic leukemia after multiple myeloma. Leukemia Research Reports. 18. 100358–100358. 4 indexed citations
14.
Kallen, Michael E., et al.. (2021). Acute Lymphoblastic Leukemia and Acute Lymphoblastic Lymphoma: Same Disease Spectrum but Two Distinct Diagnoses. Current Hematologic Malignancy Reports. 16(5). 384–393. 3 indexed citations
15.
Kallen, Michael E., et al.. (2020). Radical Tonsillectomy and Superior Pharyngeal Constrictor Anatomy: A Cadaveric and Oncologic Specimen Assessment. ORL. 82(6). 318–326. 11 indexed citations
16.
Chan, Abigail, Vincent Y. Ng, J.W. Snider, Michael E. Kallen, & Kenneth Miller. (2020). Hyperprogression of Liver Metastasis With Neoadjuvant Immunotherapy for Soft Tissue Sarcoma. Cureus. 12(6). e8575–e8575. 4 indexed citations
17.
Carlozzi, Noelle E., Michael E. Kallen, Phillip A. Ianni, et al.. (2018). The Development of a New Computer-Adaptive Test to Evaluate Strain in Caregivers of Individuals With TBI: TBI-CareQOL Caregiver Strain. Archives of Physical Medicine and Rehabilitation. 100(4). S13–S21. 23 indexed citations
18.
Kallen, Michael E., et al.. (2016). Triple Hit Lymphoma. International Journal of Surgical Pathology. 24(8). 709–714. 3 indexed citations
19.
20.
McElroy, Steven J., Stuart Hobbs, Michael E. Kallen, et al.. (2012). Transactivation of EGFR by LPS Induces COX-2 Expression in Enterocytes. PLoS ONE. 7(5). e38373–e38373. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katarzyna Drabko Breakdown of academic impact, for papers by E. Poncelet Breakdown of academic impact, for papers by Roberto Cassandro Breakdown of academic impact, for papers by Yukari Ichikawa Breakdown of academic impact, for papers by İrem Hicran Özbudak Breakdown of academic impact, for papers by ST Yuen Breakdown of academic impact, for papers by David B. Chapel Breakdown of academic impact, for papers by Pridvi Kandagatla Breakdown of academic impact, for papers by H. Aubert Breakdown of academic impact, for papers by Mami Morita
Rankless by CCL
2026